Transdermal delivery of piroxicam using microemulsions
- 334 Downloads
To improve the skin permeability of piroxicam, a new oil-in-water microemulsion containing 0.5% piroxicam was developed. Among various oils investigated for their suitability as an oil phase for the microemulsion system, oleic acid showed both excellent solubility and skin permeation enhancing effect for piroxicam. Microemulsion existence ranges were identified through the construction of the pseudo-ternary phase diagram. The effect of the content of oleic acid and the ratio of the surfactant/cosurfactant on skin permeation of piroxicam were evaluated with excised rat skins. The optimum formulation with the highest skin permeation rate (47.14 μg/cm2/h) consisted of 0.5% piroxicam, 10% oleic acid, 60% Labrasol/ethanol (1:5) and water.
Key wordsPiroxicam Microemulsion Oleic acid Phase diagram Skin permeability
Unable to display preview. Download preview PDF.
- Buyuktimkin, N., Buyuktimkin, S., and Rytting, J. H., Chemical means of transdermal drug permeation enhancement. In: Ghosh, T.K., Pfister, W.R., Yum, S.I. (Eds.), Transdermal and Topical Drug Delivery Systems, Interpharm Press, IL, pp. 357–475 (1997).Google Scholar
- Schiantarelli, P. and Cadel, S., Piroxicam pharmacology activity and gastrointestinal damage by oral and rectal route.Arzneim-Forsch., 31, 87–92 (1981).Google Scholar
- Schiantarelli, P., Cadel, S., Acerbi, D., and Pavesi, L., Anti-inflammatory activity and bioavailability of percutaneous piroxicam.Arzneim.-Forsch., 32, 230–235 (1982).Google Scholar
- Tessari, L., Ceciliani, L., Belluati, A., Letizia, G., Martorana, U., Pagliara, L., Pognani, A., Thovez, G., Siclari, A., and Torri, G., Aceclofenac cream versus piroxicam cream in the treatment of patients with minor traumas and phlogistic affections of soft tissues: a double-blind study.Curr. Ther. Res., 56, 702–712 (1995).CrossRefGoogle Scholar
- Troconiz, J. I., Lopez-Bustamante, L. G., and Fos, D., High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.Arzneim-Forsch., 43, 679–681 (1993).Google Scholar